How lithium helps treat bipolar disordersMay 22nd, 2010 - 4:46 pm ICT by ANI
Washington, May 20 (ANI): American researchers have made an advance towards uncovering lithium’s mode of action as it treats bipolar disorders.
The new research has provided solid evidence that lithium reduces brain inflammation by adjusting the metabolism of the health-protective omega-3-fatty acid called DHA.
Inflammation in the brain, like other parts of the body, is an important process to help the brain combat infection or injury.
However, excess or unwanted inflammation can damage sensitive brain cells, which can contribute to psychiatric conditions like bipolar disorder or degenerative diseases like Alzheimers.
It’s believed that lithium helps treat bipolar disorder by reducing brain inflammation during the manic phase, thus alleviating some of the symptoms.
Exactly how lithium operates, though, has been debated.
Mireille Basselin and colleagues at the National Institute of Aging and University of Colorado, Denver, took a detailed approach to this question by using mass spectrometry analysis to analyse the chemical composition of brain samples of both control and lithium-treated rats stressed by brain inflammation.
They found that in agreement with some other studies, rats given a six-week lithium treatment had reduced levels of arachidonic acid and its products, which can contribute to inflammation.
Moreover, they also demonstrated, for the first time, that lithium treatment increased levels of a metabolite called 17-OH-DHA in response to inflammation. 17-OH-DHA is formed from the omega-3 fatty acid DHA (docosahexaenoic acid) and is the precursor to a wide range of anti-inflammatory compounds known as docosanoids.
Other anti-inflammatory drugs, like aspirin, are known to also enhance docosanoids in their mode of action.
Basselin and colleagues noted that the concentration of DHA did not increase, which suggests that lithium may increase 17-OH-DHA levels by affecting the enzyme that converts DHA to 17-OH-DHA.
By reducing both pro-inflammatory AA products, and increasing anti-inflammatory DHA products, lithium exerts a double-protective effect which may explain why it works well in bipolar treatment.
The study has appeared in the May 2010 Journal of Lipid Research. (ANI)
- Omega-3 fatty acids could help prevent traumatic brain injury - Jan 09, 2011
- Turmeric may help walking ability in spinal injuries - Jun 27, 2012
- Fish can help improve nervous system function - Dec 17, 2009
- Unique genetic adaptation helped our brain grow - Apr 13, 2012
- How omega-3 fatty acids reduce inflammation - May 03, 2010
- Bingeing on soda, sweets makes you a dim wit - May 16, 2012
- Low levels of Omega fatty acids weaken memory - Feb 28, 2012
- How fish oils work against diabetes - Sep 03, 2010
- Omega-3 eases anxiety among young - Jul 14, 2011
- Finding paves way for new personalized treatments to target inflammation - Apr 05, 2011
- Omega-3 fatty acid boosts brainpower - Jun 29, 2012
- Eating fish powers brain - Oct 25, 2011
- DHA 'fish oil' supplements 'not useful for those with mild Alzheimer's' - Nov 03, 2010
- Fish oil ups risk of colon cancer in mice - Oct 06, 2010
- Omega-3 fatty acids good for heart, bad for prostate - Apr 26, 2011
Tags: american researchers, anti inflammatory drugs, aspirin, bipolar, bipolar disorders, brain cells, brain inflammation, chemical composition, degenerative diseases, lithium, lithium treatment, manic phase, mass spectrometry analysis, metabolite, omega 3 fatty acid, precursor, psychiatric conditions, rats, university of colorado, university of colorado denver